Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Re: Population-based study of contralateral prophylactic mastectomy and survival outcomes of breast cancer patients.

Tuttle TM, Habermann EB, Virnig B.

J Natl Cancer Inst. 2010 Sep 8;102(17):1371-2; author reply 1372-3. doi: 10.1093/jnci/djq298. No abstract available.

2.

Occurrence and prognosis of contralateral carcinoma of the breast.

Singletary SE, Taylor SH, Guinee VF, Whitworth PW Jr.

J Am Coll Surg. 1994 Apr;178(4):390-6. Review.

PMID:
8149039
3.

Magnetic resonance imaging screening of the contralateral breast in women with newly diagnosed breast cancer: systematic review and meta-analysis of incremental cancer detection and impact on surgical management.

Brennan ME, Houssami N, Lord S, Macaskill P, Irwig L, Dixon JM, Warren RM, Ciatto S.

J Clin Oncol. 2009 Nov 20;27(33):5640-9. doi: 10.1200/JCO.2008.21.5756. Review.

PMID:
19805685
4.

The nature of tamoxifen action in the control of female breast cancer.

Kodama M, Kodama T.

In Vivo. 2001 Jul-Aug;15(4):319-25. Review.

PMID:
11695224
5.

Prophylactic surgery for women at high risk for breast cancer.

Blanchard DK, Hartmann LC.

Clin Breast Cancer. 2000 Jul;1(2):127-34; discussion 135. Review.

PMID:
11899651
6.

Prophylactic mastectomy: why and when?

von Smitten K.

J Br Menopause Soc. 2003 Dec;9(4):151-5. Review.

PMID:
15107257
7.

The increasing use of prophylactic mastectomy in the prevention of breast cancer.

Tuttle TM, Abbott A, Arrington A, Rueth N.

Curr Oncol Rep. 2010 Jan;12(1):16-21. doi: 10.1007/s11912-009-0070-y. Review.

PMID:
20425603
8.

[Prognostic factors in breast cancer].

Jonat W, Eidtmann H, Friedrichs K.

Gynakologe. 1994 Feb;27(1):37-44. Review. German. No abstract available.

PMID:
8168736
9.

Ductal carcinoma in situ, complexities and challenges.

Leonard GD, Swain SM.

J Natl Cancer Inst. 2004 Jun 16;96(12):906-20. Review.

10.

[Complex treatment of inflammatory breast cancer].

Szántó J, Tóth J.

Magy Onkol. 2006;50(4):303-7. Review. Hungarian.

11.

[The risk-reducing mastectomy: unnecessary hysteria or life-saving prophylaxis?].

Olariu R, Shafighi M, Constantinescu MA.

Ther Umsch. 2014 Dec;71(12):759-64. doi: 10.1024/0040-5930/a000622. Review. German.

PMID:
25447091
12.

Contralateral risk-reducing mastectomy: review of risk factors and risk-reducing strategies.

Basu NN, Barr L, Ross GL, Evans DG.

Int J Surg Oncol. 2015;2015:901046. doi: 10.1155/2015/901046. Review.

13.

Using the Surveillance, Epidemiology, and End Results database to investigate rare cancers, second malignancies, and trends in epidemiology, treatment, and outcomes.

Lloyd S, Park HS, Decker RH, Wilson LD, Yu JB.

Curr Probl Cancer. 2012 Jul-Aug;36(4):191-9. doi: 10.1016/j.currproblcancer.2012.03.008. Review. No abstract available.

PMID:
22495057
Items per page

Supplemental Content

Support Center